Oncolytics Biotech Inc.

Oncolytics Biotech Inc. company information, Employees & Contact Information

Explore related pages

Oncolytics Biotech Inc. email format Oncolytics Biotech Inc. management contacts

Related company profiles:

Oncolytics Biotech Inc. is developing pelareorep, a safe and well-tolerated intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments.

Company Details

Employees
39
Founded
-
Address
322 – 11th Avenue Sw,
Phone
403.670.7377
Email
in****@****ech.com
Industry
Biotechnology
Website
oncolyticsbiotech.com
HQ
Calgary, Alberta
Competitors
OmniaBio, BlueRock Therapeutics, Virogin Biotech, Zymeworks Inc., Virica Biotech, Providence Therapeutics, Kane Biotech Inc., BioCanRx, Cannara Biotech Inc., Notch Therapeutics.
Looking for a particular Oncolytics Biotech Inc. employee's phone or email?

Oncolytics Biotech Inc. Questions

News

Oncolytics Biotech® Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada - Sahm

Oncolytics Biotech® Files Circular/Prospectus for Special Meeting of Shareholders To Change Jurisdiction of Incorporation to Nevada Sahm

Oncolytics Biotech® Announces Voluntary Delisting from the Toronto Stock Exchange - Yahoo Finance

Oncolytics Biotech® Announces Voluntary Delisting from the Toronto Stock Exchange Yahoo Finance

Clinical-Stage Cancer Biotech Oncolytics to Present at Major September Investment Conferences in NYC - Stock Titan

Clinical-Stage Cancer Biotech Oncolytics to Present at Major September Investment Conferences in NYC Stock Titan

Oncolytics Biotech® Announces Upcoming Annual General Meeting and Second Quarter Financial Results - Yahoo Finance

Oncolytics Biotech® Announces Upcoming Annual General Meeting and Second Quarter Financial Results Yahoo Finance

Oncolytics Biotech Strategic TSX Exit: What Canadian Shareholders Need to Know About Nasdaq Trading - Stock Titan

Oncolytics Biotech Strategic TSX Exit: What Canadian Shareholders Need to Know About Nasdaq Trading Stock Titan

Oncolytics Biotech® Provides Update on GOBLET Study Progress and U.S. Site Expansion - PR Newswire

Oncolytics Biotech® Provides Update on GOBLET Study Progress and U.S. Site Expansion PR Newswire

Oncolytics Biotech® Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies - Yahoo Finance

Oncolytics Biotech® Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies Yahoo Finance

Oncolytics Biotech® to Host Key Opinion Leader Discussion Focusing on Pancreatic and Gastrointestinal Cancers - Yahoo Finance

Oncolytics Biotech® to Host Key Opinion Leader Discussion Focusing on Pancreatic and Gastrointestinal Cancers Yahoo Finance

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders - PR Newswire

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders PR Newswire

Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs - Yahoo Finance

Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs Yahoo Finance

Oncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep - PR Newswire

Oncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep PR Newswire

Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy - Yahoo Finance

Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy Yahoo Finance

Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study - Yahoo Finance

Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study Yahoo Finance

Oncolytics Biotech® Provides Updated Clinical Safety Data for Pelareorep, Including Across Multiple Gastrointestinal Tumors - Yahoo Finance

Oncolytics Biotech® Provides Updated Clinical Safety Data for Pelareorep, Including Across Multiple Gastrointestinal Tumors Yahoo Finance

Oncolytics Biotech® Announces Upcoming Investor Conferences in September - Yahoo Finance

Oncolytics Biotech® Announces Upcoming Investor Conferences in September Yahoo Finance

Oncolytics Biotech® Regains Compliance with Nasdaq Trading Rules - Yahoo Finance

Oncolytics Biotech® Regains Compliance with Nasdaq Trading Rules Yahoo Finance

Oncolytics Biotech® Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions - Yahoo Finance

Oncolytics Biotech® Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions Yahoo Finance

Oncolytics Biotech® to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-End - Yahoo Finance

Oncolytics Biotech® to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-End Yahoo Finance

Oncolytics Biotech Shareholders Show 91% Support for Board, Back All AGM Proposals - Stock Titan

Oncolytics Biotech Shareholders Show 91% Support for Board, Back All AGM Proposals Stock Titan

Oncolytics Biotech® Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence - PR Newswire

Oncolytics Biotech® Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence PR Newswire

Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer - Yahoo Finance

Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer Yahoo Finance

Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence - PR Newswire

Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence PR Newswire

The Pancreatic Cancer Action Network Selects Oncolytics Biotech® Inc. to Receive $5 Million Therapeutic Accelerator Award to Develop Leading-Edge Treatments - Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network Selects Oncolytics Biotech® Inc. to Receive $5 Million Therapeutic Accelerator Award to Develop Leading-Edge Treatments Pancreatic Cancer Action Network

Oncolytics Biotech Inc. - baystreet.ca

Oncolytics Biotech Inc. baystreet.ca

Companies like Oncolytics Biotech Inc.

OmniaBio logo - Similar company to Oncolytics Biotech Inc.

Omniabio

162
Providence Therapeutics logo - Similar company to Oncolytics Biotech Inc.

Providence Therapeutics

60
Virica Biotech logo - Similar company to Oncolytics Biotech Inc.

Virica Biotech

40
Kane Biotech Inc. logo - Similar company to Oncolytics Biotech Inc.

Kane Biotech Inc.

22
Virogin Biotech logo - Similar company to Oncolytics Biotech Inc.

Virogin Biotech

32
BioCanRx logo - Similar company to Oncolytics Biotech Inc.

Biocanrx

24
BlueRock Therapeutics logo - Similar company to Oncolytics Biotech Inc.

Bluerock Therapeutics

455
Cannara Biotech Inc. logo - Similar company to Oncolytics Biotech Inc.

Cannara Biotech Inc.

138
Notch Therapeutics logo - Similar company to Oncolytics Biotech Inc.

Notch Therapeutics

24
Zymeworks Inc. logo - Similar company to Oncolytics Biotech Inc.

Zymeworks Inc.

303

Top Oncolytics Biotech Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant